首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   105篇
  免费   6篇
  2020年   2篇
  2015年   3篇
  2014年   1篇
  2013年   3篇
  2012年   5篇
  2011年   1篇
  2010年   1篇
  2009年   1篇
  2008年   6篇
  2007年   7篇
  2006年   4篇
  2005年   3篇
  2004年   3篇
  2003年   2篇
  2002年   6篇
  2001年   1篇
  2000年   1篇
  1999年   2篇
  1998年   9篇
  1997年   2篇
  1995年   1篇
  1994年   1篇
  1993年   4篇
  1992年   1篇
  1991年   3篇
  1990年   2篇
  1989年   2篇
  1987年   1篇
  1986年   1篇
  1985年   1篇
  1984年   2篇
  1982年   1篇
  1980年   1篇
  1977年   1篇
  1976年   1篇
  1975年   1篇
  1974年   2篇
  1973年   4篇
  1972年   1篇
  1969年   3篇
  1968年   2篇
  1967年   1篇
  1965年   1篇
  1964年   1篇
  1962年   2篇
  1960年   1篇
  1958年   1篇
  1947年   1篇
  1903年   1篇
  1890年   1篇
排序方式: 共有111条查询结果,搜索用时 734 毫秒
101.
Four New World genera of dwarf boas (Exiliboa, Trachyboa, Tropidophis, and Ungaliophis) have been placed by many systematists in a single group (traditionally called Tropidophiidae). However, the monophyly of this group has been questioned in several studies. Moreover, the overall relationships among basal snake lineages, including the placement of the dwarf boas, are poorly understood. We obtained mtDNA sequence data for 12S, 16S, and intervening tRNA-val genes from 23 species of snakes representing most major snake lineages, including all four genera of New World dwarf boas. We then examined the phylogenetic position of these species by estimating the phylogeny of the basal snakes. Our phylogenetic analysis suggests that New World dwarf boas are not monophyletic. Instead, we find Exiliboa and Ungaliophis to be most closely related to sand boas (Erycinae), boas (Boinae), and advanced snakes (Caenophidea), whereas Tropidophis and Trachyboa form an independent clade that separated relatively early in snake radiation. Our estimate of snake phylogeny differs significantly in other ways from some previous estimates of snake phylogeny. For instance, pythons do not cluster with boas and sand boas, but instead show a strong relationship with Loxocemus and Xenopeltis. Additionally, uropeltids cluster strongly with Cylindrophis, and together are embedded in what has previously been considered the macrostomatan radiation. These relationships are supported by both bootstrapping (parametric and nonparametric approaches) and Bayesian analysis, although Bayesian support values are consistently higher than those obtained from nonparametric bootstrapping. Simulations show that Bayesian support values represent much better estimates of phylogenetic accuracy than do nonparametric bootstrap support values, at least under the conditions of our study.  相似文献   
102.

Background

Guidelines recommend intensive blood pressure (BP) lowering in patients at high risk. While placebo-controlled trials have demonstrated 22% reductions in coronary heart disease (CHD) and stroke associated with a 10-mmHg difference in systolic BP, it is unclear if more intensive BP lowering strategies are associated with greater reductions in risk of CHD and stroke. We did a systematic review to assess the effects of intensive BP lowering on vascular, eye, and renal outcomes.

Methods and Findings

We systematically searched Medline, Embase, and the Cochrane Library for trials published between 1950 and July 2011. We included trials that randomly assigned individuals to different target BP levels.We identified 15 trials including a total of 37,348 participants. On average there was a 7.5/4.5-mmHg BP difference. Intensive BP lowering achieved relative risk (RR) reductions of 11% for major cardiovascular events (95% CI 1%–21%), 13% for myocardial infarction (0%–25%), 24% for stroke (8%–37%), and 11% for end stage kidney disease (3%–18%). Intensive BP lowering regimens also produced a 10% reduction in the risk of albuminuria (4%–16%), and a trend towards benefit for retinopathy (19%, 0%–34%, p = 0.051) in patients with diabetes. There was no clear effect on cardiovascular or noncardiovascular death. Intensive BP lowering was well tolerated; with serious adverse events uncommon and not significantly increased, except for hypotension (RR 4.16, 95% CI 2.25 to 7.70), which occurred infrequently (0.4% per 100 person-years).

Conclusions

Intensive BP lowering regimens provided greater vascular protection than standard regimens that was proportional to the achieved difference in systolic BP, but did not have any clear impact on the risk of death or serious adverse events. Further trials are required to more clearly define the risks and benefits of BP targets below those currently recommended, given the benefits suggested by the currently available data. Please see later in the article for the Editors'' Summary.  相似文献   
103.
104.
105.
106.
107.
108.
109.
110.
Synopsis A subgenomic library created from genomic DNA of Latimeria chalumnae was screened for 28S ribosomal RNA (rRNA) clones. The resulting clone was subcloned into a plasmid vector, and over 2 kb of the 28S rRNA region was sequenced. Sequences of 28S rRNA genes were also obtained for Rhineura floridana (Squamata), Cyprinella lutrensis (Actinopterygii), and Lampetra aepyptera (Petromyzontiformes) by cloning and/or amplification by the polymerase chain reaction. The 28S rDNA sequences were aligned for all the above species as well as for the previously published 28S rDNA sequences of the genera Mus, Rattus, and Homo (Mammalia), Xenopus (Amphibia), and Drosophila (Insecta). Phylogenetic analysis of these species (using both the insect and lamprey sequences for outgroup comparison, or using only the lamprey sequence in the outgroup) produced a single optimal solution: (Outgroup(Cyprinella(Latimeria(Xenopus(Rhineura(Homo(Rattus(Mus)))))))). Bootstrap analysis indicated that the placement of L. chalumnae on this tree was significant at p < 0.01. Previously published alternative hypotheses of relationships of Latimeria require at least 19 additional steps compared to the optimal solution; the rDNA data are sufficient to reject the hypotheses that place Latimeria in groups other than the sarcopterygians.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号